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Background. There is a widespread interest in developing renewable sources of islet-replacement tissue for type I diabetes
mellitus. Human mesenchymal cells isolated from the Wharton’s jelly of the umbilical cord (HUMSCs), which can be easily
obtained and processed compared with embryonic and bone marrow stem cells, possess stem cell properties. HUMSCs may be
a valuable source for the generation of islets. Methodology and Principal Findings. HUMSCs were induced to transform into
islet-like cell clusters in vitro through stepwise culturing in neuron-conditioned medium. To assess the functional stability of
the islet-like cell clusters in vivo, these cell clusters were transplanted into the liver of streptozotocin-induced diabetic rats via
laparotomy. Glucose tolerance was measured on week 12 after transplantation accompanied with immunohistochemistry and
electron microscopy analysis. These islet-like cell clusters were shown to contain human C-peptide and release human insulin
in response to physiological glucose levels. Real-time RT-PCR detected the expressions of insulin and other pancreatic b-cell-
related genes (Pdx1, Hlxb9, Nkx2.2, Nkx6.1, and Glut-2) in these islet-like cell clusters. The hyperglycemia and glucose
intolerance in streptozotocin-induced diabetic rats was significantly alleviated after xenotransplantation of islet-like cell
clusters, without the use of immunosuppressants. In addition to the existence of islet-like cell clusters in the liver, some special
fused liver cells were also found, which characterized by human insulin and nuclei-positive staining and possessing secretory
granules. Conclusions and Significance. In this study, we successfully differentiate HUMSCs into mature islet-like cell clusters,
and these islet-like cell clusters possess insulin-producing ability in vitro and in vivo. HUMSCs in Wharton’s Jelly of the
umbilical cord seem to be the preferential source of stem cells to convert into insulin-producing cells, because of the large
potential donor pool, its rapid availability, no risk of discomfort for the donor, and low risk of rejection.
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Cord for Transplantation to Control Type 1 Diabetes. PLoS ONE 3(1): e1451. doi:10.1371/journal.pone.0001451
INTRODUCTION
Type 1 diabetes accounts for only about 5–10% of all cases of
diabetes; however, its incidence continues to increase worldwide and
it has serious short-term and long-term implications [1]. Transplan-
tation of pancreatic islet cells as a potential cure for type I diabetes
mellitus has become the subject of intense interest over the past two
decades [2–4]. A protocol, characterized by the infusion of multiple,
fresh donor islets followed by the host immune suppression with
nonsteroidal immunosuppressive regimen, has proved to be effective
in treating severe cases of type I diabetes [2]. However, the problem
of the worldwide shortage of transplant-ready islets has yet to be
resolved. Moreover, islet transplantation has been hampered by
immune rejection and recurrent attacks against islets by the
underlying autoimmunity [2,5]. Immunosuppressive regimens are
capable of preventing islet failure for months to years, but these
regimens may increase the risk for specific malignancies and
opportunistic infections [6]. Ironically, all commonly used immu-
nosuppressive drugs (steroids, calcineurin inhibitors, and rapamycin)
have been reported to have adverse effects on pancreatic b-cells [7].
Therefore, these factors motivate efforts to develop renewable
sources of islet-replacement tissue.
Many studies have made efforts to expand pancreatic islets and
to develop renewable sources of islet-replacement tissue. Recent
studies have shown that embryonic stem cells [8,9], pancreatic
ductal cells [10,11], hepatic stem cells [12], neural progenitor cells
[13], bone marrow-derived cells [14,15], or umbilical cord blood
cells [16,17], may be possible sources to derive transplantable
insulin-producing cells or islet-replacement tissues. In most of these
studies, with respect to the test of functional b-cell generation, the
insulin-producing cells or tissues were transplant into immuno-
compromised recipient animal with or without streptozotocin-
induced diabetes mellitus. Both embryonic stem cells and fetus-
derived stem cells have ethical problems that impede their
application into the clinic. Postnatal stem cells offer fewer concerns
in terms of moral issues.
Human mesenchymal cells isolated from the Wharton’s jelly of
the umbilical cord, which can be easily obtained and processed
compared to embryonic and bone marrow stem cells, possess stem
cell properties [18–20]. These postnatal stem cells have broad
developmental potential, which could be induced to differentiate
into neuron-like cells, osteogenic, chondrogenic, adipogenic, and
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studies showed that no rejections occur even after xenotransplan-
tation of post-differentiated umbilical cord mesenchymal stem cells
without immunosuppression therapy [21,22]. The potential of
umbilical cord mesenchymal stem cells to form insulin-producing
cells has not yet been evaluated. Therefore, the availability of
human umbilical cord mesenchymal stem cells allowed us to
investigate whether these stem cells could develop into glucose-
responsive insulin-producing cells. Here, we describe experimental
strategy for developing pancreatic islet-like cell clusters directly
from human mesenchymal stem cells isolated from Wharton’s jelly
of the umbilical cord.
RESULTS
Four stage differentiation protocol and
morphological changes of HUMSCs
The neuronal conditioned medium (NCM) was made from rat
brain, on which HUMSCs were growing and differentiated into
nestin positive cells. The level of nestin-positive cells reached a
peak on the day 7, represented by red fluorescence detected on
immunocytochemistry study using anti-nesting antibodies (Figs. 1
and 2). Under inversed microscope, undifferentiated HUMSCs
(stage 1) were typically adherent spindle shape (Fig. 1). These
spindle-like cells became aggregates (stage 2), and some formed
clusters under neuronal conditioned medium (NCM) (Figs. 1 and
2). These spindle-shape cells became round or oval-type cells in
the medium containing high glucose (25 mM), insulin, nicotin-
amide, and B27, and later formed clusters (stage 3; Fig. 1). These
cells continued to differentiate and eventually resulted in larger
clusters under stage 3 medium supplemented with SCM (stage 4;
Figs. 1 and 2).
Immunocytochemistry was performed to test nestin, insulin, and
glucogan protein expressions in stage 2 and stage 4 of HUMSCs
differentiation. Nestin was regarded as an important marker for
initiation of islet cells differentiation. There were no insulin and
glucagon expressions in cells of stage 2 of HUMSCs differentiation,
but it showed more nestin-staining cells than cells in stage 4. In cells
ofstage4,thereweremoreinsulinandglucagonexpression(Fig.2A).
Moreover, by using real-time reversetranscription-polymerasechain
reaction, the mRNA expressions of insulin and other pancreatic b-
cell-related genes, such as Pdx1, Hlxb9, Nkx2.2, Nkx6.1,a n dGlut-2
were observed to be significantly activated in stage 4 islet-like cell
clusters (Fig. 2B-a), but it was not observed in stage 2 cells (data not
shown). The comparison of insulin mRNA expression levels in stage
4 islet-like cell clusters relative to isolated human islets as well as a rat
b-cell line RIN-m5F was also tested. As shown in figure 2B-b, the
relative insulin mRNA expressions in stage 4 islet-like clusters/
human islets and stage 4 islet-like clusters/RIN-m5F were
0.5860.16 and 0.4160.12, respectively.
The cell clusters in stage 4 secreted lower levels of insulin on low
glucose (5.5 mM) DMEM medium, but secreted higher levels of
insulin on high glucose (25 mM) DMEM medium, which was
similar to pancreatic b-cells (Fig. 3A). Moreover, C-peptide, a
product of insulin formation, represents new insulin formation
instead of insulin absorption from the medium. The cell clusters in
stage 4 secreted much higher levels of C-peptide than the cell
Figure 1. Outline of differentiation protocol and stage-specific cell
cluster morphology. Essential factor manipulations at each stage were
also shown. Original magnification: 640.
doi:10.1371/journal.pone.0001451.g001
Figure 2. Detections of nestin, glucagons, insulin, and pancreatic b-
cell-related genes in stage-specific cell cluster. In A, immunocyto-
chemical detection of nestin, glucagon and insulin in stage 2 and stage
4 of differentiated human umbilical cord mesenchymal stem cells.
Immunofluorescent images were obtained by confocal microscopy and
are representative of at least 6 samples for each antibody. In g and h,
DAB was a substrate for the immunostaining of insulin. Results shown
are representative of three independent experiments. Original magni-
fication: 640. In B-a, real-time RT-PCR detected the mRNA expressions
of insulin and other pancreatic b-cell-related genes, such as Pdx-1,
Hlxb9, Nkx2.2, Nkx6.1, and Glut-2 in these islet-like cell clusters. In B-b,
real-time RT-PCR detected the insulin mRNA expressions in stage 4 cell
clusters comparing to human islets or rat b-cell line RIN-m5F. Data are
presented as means6SEM from three independent experiments.
doi:10.1371/journal.pone.0001451.g002
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clusters release insulin in response to the physiological glucose
concentrations in vitro.
Improved glucose regulation and circulating insulin
levels in STZ-induced diabetic rats by stage 4 cell
clusters transplantation
To assess the functional stability of the islet-like cell clusters in vivo,
islet-like cell clusters were transplanted into the liver of STZ-
induced diabetic rats via laparotomy. One week after sham
transplantation, STZ-treated control rats became hyperglycemia
(439.33658.41 mg/dl; Fig. 4A). In STZ-induced diabetic rats
xenografted with stage 4 islet-like cell clusters, hyperglycemia was
markedly attenuated (171.17636.90 mg/dl; Fig. 4A) compared
with sham-transplanted controls during random-feeding. There is
no immunosuppressant used in these islet-like cell clusters-
transplanted rats. Moreover, serum human insulin level was also
detected during random-feeding. The serum human insulin level
was near absent in sham-transplanted control and STZ-treated
rats. The Insulin levels in STZ-treated rats transplanted with stage
4 islet-like cell clusters for one week were increased
(2.5660.34 mU/L; Fig. 4B) and maintained to week 12 after
transplantation (Fig. 4C). The cross-reaction between human
insulin and rat insulin is very low (about 0.7%) in insulin ELISA kit
(Mercodia, Sweden).
The level of hyperglycemia was lowered starting 3 days after
transplantation. Hyperglycemia was normalized thereafter and
stable blood glucose levels were maintained for .9 weeks, until
the experiment was terminated for immunohistochemical analysis
(Fig. 5A). No hypoglycemia was noted at the end of the
experiment. The STZ-diabetic rats lost weight persistently and
Figure 3. In vitro insulin and C-peptide secretion assay of islet-like
cell clusters. In A, insulin release in response to physiological (5.5 mM)
and high (25 mM) glucose concentrations of stage 4 cell cluster was
measured after 24 h incubation. In B, C-peptide secretion of stage 3 and
stage 4 cell clusters was detected. All data are presented as
means6SEM (n=6 in A; n=8 in B).
doi:10.1371/journal.pone.0001451.g003
Figure 4. Changes of blood glucose and serum human insulin levels in
STZ-diabetic rats after clusters transplantation. Blood glucose (A) and
serum human insulin (B) detection 1-week after sham or stage 4 islet-like
cell cluster transplantation in STZ-induced diabetic rats. Random-fed
blood glucose levels were measured in all groups. In C, time-course
changes of serum human insulin levels after transplantation. All data are
presented as means6SEM (n=6 in each group). * P,0.05 as compared
with before STZ.
# P,0.05 as compared with after STZ.
doi:10.1371/journal.pone.0001451.g004
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transplantation (Figs. 5B and C). To further evaluate the function
of the implanted islet-like cell clusters, we performed an IPGT test
on normal, STZ-diabetic and transplanted STZ-diabetic rats after
12-week transplantation. As shown in Figure 6, the result of IPGT
testing indicated a normal rate of glucose clearance after
transplantation of islet-like cell clusters, but not the transplantation
of undifferentiated HUMSCs. Subsequently, immunohistochemi-
cal analysis detected human insulin immunofluorescence staining
in the transplanted islet-like cell clusters in the liver (Fig. 7A).
Unexpectedly, human insulin immunofluorescence staining was
also detected in the non-cell clusters region of liver in STZ-diabetic
rat transplanted with stage 4 islet-like cell clusters. The cell size
and morphology of these human insulin-positive staining cells are
similar with hepatocytes. The human origin of the engrafted cells
was confirmed by immunohistochemistry using the anti-human
nuclei monoclonal antibody (Fig. 7B-c, in green). The merged
image of human insulin and human nuclei immunostaining was
shown in Figure 7B-d. There was no human insulin and human
nuclei immunostaining in the sham liver of STZ-diabetic rat
without transplantation of cell clusters (Fig. 7B-h-j). These findings
indicated that implanted islet-like cell clusters and human insulin
and nuclei-positive staining liver cells are simultaneously existed in
the liver after transplantation of stage 4 islet-like cell clusters for
3 months. Next, we further investigated these human insulin and
nuclei-positive staining liver cells using electron microscopy
(Figs. 7B-e-g). These cells possessed secretory granules densely
packed in the cytoplasm. These secretory granules were small
(300–600 nm in diameter) and possessed electron-dense cores.
Crystalline formation was detected in the cores of the granules, a
feature that is characteristic of secretory granules in normal
pancreatic cells of rodents.
DISCUSSION
Recent studies have demonstrated the feasibility of generating
insulin-producing cells obtained from progenitor cells of various
cellular sources [8–15]. Despite their promising potential, it also
proved difficult to obtain enough autologous adult stem cells from
these organs. Some obstacles, such as the immune rejection and
autoimmunity against newly formed b-cells derived from pancre-
atic stem cells, still remain. To overcome these limitations, we
explored the possibility of using HUMSCs in Wharton’s Jelly of
the umbilical cord as a source for cellular differentiation into
Figure 5. Functional transplantation of stage 4 islet-like cell clusters
alleviates hyperglycemia, decreased body weight and decreased
survival ratio in STZ-induced diabetic rats. STZ-induced diabetic rats
(blood glucose levels .400 mg/dl) were transplanted with stage 4
insulin secreting islet-like clusters. Random-fed blood glucose levels
were measured in untreated control rats with sham, STZ-treated rats
with sham, and STZ-treated rats with transplantation of islet-like cell
clusters or undifferentiated HUMSCs (undiff-HUMSCs). The changes in
blood glucose (A), body weight (B) and survival ratio (C) were observed.
All data are presented as means6SEM (n=6 in each group).
doi:10.1371/journal.pone.0001451.g005
Figure 6. Correction of glucose intolerance in STZ-induced diabetic
rats transplanted with stage 4 islet-like cell clusters. Intraperitoneal
glucose tolerance test performed on post-transplantation week 12 in
untreated control rats with sham, STZ-treated rats with sham, and STZ-
treated rats with transplantation of islet-like cell clusters or undifferen-
tiated HUMSCs (undiff-HUMSCs). All data are presented as means6SEM
(n=6 in each group).
doi:10.1371/journal.pone.0001451.g006
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HUMSCs in Wharton’s Jelly of the umbilical cord are easily
obtained compared with embryonic and other stem cells. In our
previous and present studies, approximately 1610
6 HUMSCs
were collected from a 20-cm of umbilical cord [21]. The doubling
time of HUMSCs in 10% FBS-DMEM is 3 days. Wharton’s Jelly
cells have been cultured for more than 80 population doublings
with no indications of senescence, changes in morphology,
increased growth rate, or change in ability to differentiate into
neurons [20]. The transformed HUMSCs in the striatum have
been demonstrated to be viable 4 months after transplantation
without the need for immunological suppression [21]. The study of
Weiss and colleagues has also shown the stem cells from human
umbilical cord Wharton’s Jelly that were transplanted into normal
rats did not produce brain tumors, rotational behavior, or a frank
host immune rejection response [22]. In the present study,
HUMSCs were induced to transform into pancreatic islet-like cell
clusters in vitro through stepwise culturing in neuron-conditioned
medium and stem cell-conditioned medium. These islet-like cell
clusters were shown to contain human C-peptide and release
insulin in response to physiological glucose levels. Real-time RT-
PCR analysis also showed the enhancement of insulin and other
pancreatic b-cell-related genes, such as Pdx1, Hlxb9, Nkx2.2,
Nkx6.1, and Glut-2 in these islet-like cell clusters. Moreover, the
hyperglycemia was significantly under control in streptozotocin-
induced diabetic rats after xenotransplantation of these human
pancreatic islet-like cell clusters. Even without the use of
immunosuppressants, there was no evidence of rejection. There-
fore, HUMSCs in Wharton’s Jelly of the umbilical cord represent
not only a safe and abundant source for large quantities of stem
cells, but also one that is easily manipulated and free of ethical
problems.
Pancreatic endocrine cells were originally proposed to be of
neuronal origin, because of its neuronal-marker expression. On
the other hand, it has been unequivocally established that they
arise from the endoderm [23]. In some invertebrate species, such
as Drosophila, brain neurons were the main source of circulating
insulin [24,25]. Insulin gene transcription has also been identified
in the vertebrate brain [26]. It has been shown that multipotent
precursor cells from the adult mouse pancreas can form clonal
colonies, which express both neural and pancreatic precursor
markers, generating distinct populations of neurons and glial cells,
pancreatic endocrine cells, and pancreatic exocrine and stellate
cells [27]. These findings indicated the similarities between islet
cells and neurons. Treutelaar and colleagues have reported that
nestin-lineage cells contribute to the microvasculature but not
endocrine cells of the islet [28]. Delacour and colleagues have also
shown that nestin is expressed in the pancreatic exocrine cell
lineage, but the consistent nestin expression is not a major feature
of islet endocrine progenitor cells [29]. However, recent study of
Hori and colleagues suggested that brain-derived human neural
progenitor cells, when exposed to a series of signals that regulate in
vivo pancreatic islet development, form clusters of glucose-
responsive insulin-producing cells [13]. In the present study, the
neuronal conditioned medium was made from rat brain, on which
HUMSCs grew and differentiated into nestin-positive cells.
Expression of nestin reflects the differentiating state of neural
progenitor cells in the developing central nervous system [30,31].
These nestin-positive cells were then changed into insulin-
producing cells under the medium containing high glucose, high
insulin, nicotinamide, and B27, later forming the islet-like cell
clusters. Nicotinamide is a poly (ADP-ribose) synthetase inhibitor
known to differentiate and increase b-cell mass in cultured human
fetal pancreatic cells [32], as well as to protect b-cells from
desensitization induced by prolonged exposure to large amounts of
glucose [33]. Our immunocytochemical analysis showed that stage
4 islet-like cell clusters do not express nestin, implying that these
cell clusters are non-neuronal. The real-time RT-PCR analysis
showed the enhancement of insulin and other pancreatic b-cell-
related genes also imply that these insulin-producing cells in islet-
like cell clusters are b-cells or b-cell-like cells.
High glucose condition has been useful for isolating and
maintaining progenitor cell populations from the nervous systems
[34,35] and for permitting differentiation by neurogenic cells
[13,36]. Hori and colleagues have found that human neural
Figure 7. Histological analysis of the liver of STZ-induced diabetic
rats transplanted with stage 4 islet-like cell clusters for 12 weeks. In
A-a and -b, hematoxylin and eosin-stained sections of liver with cell
cluster. In A-c-e, individual (c, d) and merged (e) fluorescent images of
liver sections from STZ-induced diabetic rats transplanted with islet-like
cell clusters. Sections were stained with a anti-human insulin antibody
(green) (d and e) with or without 4,6-diamidino-2-phenylindole (DAPI;
blue) (c and e). Image b to e is from consecutive section of a. Original
magnification: 620 (a); 6100 (b-e). In A-f, individual fluorescent image
of liver section from STZ-induced diabetic rats (sham, without
transplantation of islet-like cell clusters). Section was stained with an
anti-human insulin antibody. In B-a, hematoxylin and eosin-stained
sections of liver. In B-b-e, individual (b, c and d) and merged (e)
fluorescent images of liver sections from STZ-induced diabetic rats
transplanted with islet-like cell clusters. Sections were stained with an
anti-human nuclei antibody (red) (b, c and e) without or with anti-
human insulin antibody (green) (d and e). The human origin of the
engrafted cells was established by immunohistochemistry by using the
anti-human nuclei monoclonal antibody. Image c to e is from
consecutive section of a. Original magnification: 6100. In B-f-h,
individual (f and g) and merged (h) fluorescent images of liver sections
from STZ-induced diabetic rats (sham, without transplantation of islet-
like cell clusters). Sections were stained with an anti-human nuclei
antibody (f and h) without or with anti-human insulin antibody (g). In B-
i-k, electron microscopy of secretory granules within liver cells of liver
sections from STZ-induced diabetic rats transplanted with islet-like cell
clusters. The presence of secretory granules with crystalline formation is
evident at high magnification (arrow). Original magnification:65000 (i);
68000 (j); 620000 (k). All results shown are representative of three
independent experiments.
doi:10.1371/journal.pone.0001451.g007
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cell cluster [13]. In our study, the nestin-positive cells developed
into insulin-producing cells under high glucose condition.
However, prolonged exposure to high glucose condition not only
severely reduced insulin expression in b-cells, but also resulted in
b-cell apoptosis [37,38]. Unexpectedly, we found that supple-
mented stem cell-conditioned medium provides the functions of
protection and regeneration in stage 4 islet-like cell clusters. These
findings imply that some factors in stem cell-conditioned medium
promote islet-like cell clusters differentiation and prevent glucose-
induced toxicity. The mechanism of action of stem cell-
conditioned medium on islet-like cell clusters needs to clarify in
the future.
Type 1 diabetes has always been known as a disease of
childhood, but more recent epidemiological studies have indicated
that the incidence is comparable in adults [39]. Type 1 diabetes
has a strong genetic component, inherited mainly through the
HLA complex, although the factors that trigger onset of clinical
disease remain unknown [1,39]. Susceptibility for type 1 diabetes
is largely inherited by genes predominantly in the HLA genotypes
DR and DQ. Both high risk and protective HLA haplotypes have
been identified [1]. These susceptibility genes are thought to be
important regulators of the cellular immune response. Moreover,
HUMSCs in Wharton’s Jelly of the umbilical cord have been
demonstrated to have genetic and surface markers of mesenchy-
mal stem cells: positive for CD10, CD13, CD29, CD44, and
CD90 and negative for CD14, CD33, CD56, CD31, CD34,
CD45, and HLA-DR [22]. In the present study, therefore, lack of
HLA-DR maybe the one of reasons that differentiated HUMSCs
can survive during xenotransplantation, and implies that the
differentiated HUMSCs can appear invisible to the effects of the
underlying autoimmunity.
Cell fusion has recently been suggested to possess the ability to
produce viable cells and to induce cells from one tissue type to
form other tissue types after transplantation [40–43]. It has been
demonstrated that transplanted bone-marrow-derived cells fuse in
vivo with hepatocytes in liver, Purkinje neurons in the brain, and
cardiomyocytes in the heart [42]. Wang and colleagues have
suggested that hepatocytes derived form bone marrow arise from
cell fusion and not by differentiation of haematopoietic stem cells
[43]. In the present study, from the analysis of immunohisto-
chemistry, the liver transplanted with cell clusters not only
contained islet-like cell clusters, but also possessed human insulin
and nuclei-positive staining liver cells. The detection by electron
microscopy showed that these human insulin and nuclei-positive
staining liver cells contained one nucleus, a mitochondria-rich
cytoplasm, and a very well developed endoplasmic reticulum; but
there were multiple dense secretory granules and less glycogen
storage granules in the cytoplasm. Therefore, cell fusion of
transplanted cells into liver cells is suspected. Since transplanted
cell clusters could still be found 3 months after transplantation, cell
fusion is thought to be one of the reason that no rejection occurred
in the animals, which implanted the stage 4 islet-like cell clusters.
Moreover, our results showed that high blood glucose level of the
STZ-induced diabetic rats was rapidly declined to less than
200 mg/dl on day 3 after transplantation of stage 4 cell clusters. If
there were not enough functional islet-like cell clusters in the early
stage of transplantation, the blood glucose level should not be
normalized so rapidly. Nevertheless, the maintenance of normal-
ized blood glucose level during transplantation may need the
formation of fused liver cells (human insulin and nuclei-positive
staining and contained secretory granules) through a possible cell
fusion pathway. The detail mechanism needs further investigation
in the future.
In conclusion, in this study, we successfully differentiate
HUMSCs into mature islet-like cell clusters, that possess insulin-
producing ability in vitro and in vivo. HUMSCs in Wharton’s Jelly of
the umbilical cord seem to be a favorable source of stem cells for
conversion into insulin-producing cells, because of its large
potential donor pool, rapid availability, absence of discomfort to
the donor, and low risk of rejection. Therefore, HUMSCs in
Wharton’s Jelly of the umbilical cord have the potential to become
an excellent candidate in b-cell replacement therapy of diabetes.
MATERIALS AND METHODS
Preparation of Human Umbilical Mesenchymal Stem
Cells (HUMSCs)
With the consent of the parents, fresh human umbilical cords were
obtained after birth and collected in HBSS (Gibco) at 4uC.
Following disinfection in 75% ethanol for 30 s, the umbilical cord
vessels were cleared off in HBSS. HUMSCs were prepared as
previously described [21]. The mesenchymal tissue (in Wharton’s
jelly) was diced into cubes of about 0.5 cm
3 and centrifuged at
2506g for 5 min. Following removal of the supernatant fraction,
the precipitate (mesenchymal tissue) was washed with serum-free
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) and
centrifuged at 2506g for 5 min. The mesenchymal tissue was
treated with collagenase at 37uC for 18 h, washed and further
digested with 2.5% trypsin (Gibco) at 37uC for 30 min. Fetal
bovine serum (FBS) (Hyclone) was added to the mesenchymal
tissue to neutralize the excess trypsin. The dissociated mesenchy-
mal cells were further dispersed by treatment with 10% FBS-
DMEM and counted. The mesenchymal cells were then used
directly for cultures or stored in liquid nitrogen for later use.
Moreover, in some experiments, the stem cell-conditioned
medium (SCM) was used. The preparation of SCM: the
mesenchymal cells were suspended in 12 ml of DMEM/F12,
2% FBS, 1 mM glutamine, 10 mM nicotinamide. After 3 days
culture, the medium (SCM) was ready for usage in stage 4 of
HUMSCs differentiation.
Preparation of Neuronal Conditioned Medium
(NCM)
NCM was prepared as previously described [21]. Seven-day
postnatal Sprague-Dawley rats were anesthetized by intraperito-
neal injection of 10% chloride hydrate. The brain was removed,
placed in Ca
2+/Mg
2+-free buffer (Gibco) and centrifuged at
900 rpm for 5 min. Following removal of the supernatant fraction,
10% FBS-DMEM was added to the precipitate (brain tissue). The
brain tissue suspension was triturated 15 times for dispersal into
single cells. The cells were suspended in 10% FBS-DMEM and
incubated at 37uCi n5 %C O 2 and 95% O2. The next day, AraC
(Sigma-Aldrich) at a concentration of 2 mM was added. On the 5
th
day of culture, the culture medium (NCM) was removed to be used
for the culture of umbilical mesenchymal cells. To generate nestin-
positive cells, HUMSCs were cultured in NCM alone, which was
replaced every other day.
Generation of Islet-Like Cell Clusters from
Undifferentiated HUMSCs in Vitro
In vitro differentiation of HUMSCs into islet-like cell clusters was
carried out by four stages. In stage 1, undifferentiated HUMSCs
were cultured and expanded in 10% FBS/DMEM for 3 to 6 days.
In stage 2, HUMSCs were cultured in NCM alone for 7 days,
which was replaced every other day to induce nestin-positive cells.
In stage 3, cells were cultured in 2% FBS/DMEM (25 mM
Islet-Like Cluster from HUMSCs
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amide and B27 (GIBCO) for 7 days. In stage 4, differentiated
premature islet-like cell clusters were cultured in stage 3 medium
and supplemented with SCM for 14 days. The outcome of this
procedure produced many islet-like cell clusters, which could
express insulin and glucagon as shown in figures 1 and 2.
Human Insulin and C-Peptide Quantification and In
Vitro Insulin Secretion Assay
For in vitro insulin secretion assay, twenty stage 4 cell clusters were
handpicked, washed with PBS 5 times to prevent insulin assay
cross reaction with medium, and then cultured in 2% FBS/
DMEM (5.5 mM glucose) without B27 and nicotinamide for 24 h.
Next, clusters were washed with PBS 5 times again and cultured in
2% FBS/DMEM (25 mM glucose) without B27 and nicotinamide
for 24 h. Supernatants from medium for 5.5 or 25 mM glucose-
stimulated clusters were harvested for enzyme-linked immunosor-
bent assay (ELISA)-based quantification of released insulin
(Mercodia, Sweden). Moreover, C-peptide in medium of stage 3
and 4 cell clusters was determined using ELISA kit (Mercodia,
Sweden), according to the manufacturer’s instruction.
RNA Extraction and Real-Time Polymerase Chain
Reaction
Total RNA was extracted from stage1, stage3, stage4, human islets
and RIN-m5F cells using TRIzol (Gibco, California USA) and
following the manufacturer’s recommendations. The resulting
products were amplified using the following primers: insulin
(192 bp), forward 59-TTCTTCTACACACCCAAGAC-39, re-
verse 59-CTAGTTGCAGTAGTTCTCCA-39, Pdx1 (198 bp),
forward 59-TGGATGA- AGTCTACCAAAGC-39, reverse 59-
GGTCAAGTTCAACATGACA- G-39, Hlxb9 (197 bp), forward
59-TAAGATGCCCGACTTCAAC-39, reverse 59-TGGAA-
CCAAATCTTCACCT-39, Nkx2.2 (227 bp), forward 59-ATG-
TAAACGTT- CTGACAACT-39, reverse 59-TTCCATATTT-
GAGAAATGTTTGC-39, Nkx6.1 (215 bp), forward 59-
CTATTCGTTGGGGATGACA-39, reverse 59-AGCTGC-
GTGATTTTC- T-39, Glut-2 (196 bp), forward 59-GAATAA-
CATTGCCAAACGTC-39, reverse 59-AAGAAC- CATCAG-
CATGTC-39. Rat insulin primer, forward 59-TGG TTT CTT
CTA CAC ACC C-39, reverse 59-CTC AGT TGC AGT AGT
TCT C-39. cDNA was prepared from 5 mg of total RNA following
DNase treatment and 10 ng RNA equivalent used for PCR with
specific primers in the presence of SYBR Green I (Light Cycler
TM-
FastStart DNA Master SYBR green I (Rouche)), as previously
described [44]. A melt curve analysis was performed at the end of
each reaction. Expression levels were normalized to individual
GAPDH (internal control). The profile was obtained by plotting
relative gene expression levels comparing to undifferentiated
HUMSCs (stage 1 cells).
RIN-m5F cells and human islets culture
RIN-m5F cells (ATCC, CRL-11605) were cultured in RPMI 1640
medium with 2 mM L-glutamine adjusted to contain 1.5 g/L
sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1 mM
sodium pyruvate, and supplemented with 10% fetal bovine serum
and 100 mg/ml streptomycin, 100 units/ml penicillin at 37uCi n
an atmosphere of 95% air/5% CO2. Moreover, human islets were
isolated by collagenase digestion from the surrounding non-tumor
pancreatic tissue, which was taken from patient with benign
pancreatic tumor after obtaining written informed consent. This
experiment was approved by the Research Ethics Committee at
the National Taiwan University Hospital. Human islets were
cultured in CMRL 1066 medium (5.5 mM glucose) containing
10% FCS, 100 mg/ml streptomycin, 100 units/ml penicillin,
1 mM sodium pyruvate, 2 mM L-glutamine, and 2 mM HEPES.
Insulin Secreting Cells Transplantation
Sprague-Dawley rats (200–250 g) were purchased from the
Animal Center of the College of Medicine, National Taiwan
University (Taipei, Taiwan). The Animal Research Committee of
College of Medicine, National Taiwan University, conducted the
study in accordance with the guideline for the care and use of
laboratory animals. Experimental diabetes was induced 7 days
before transplantation by intraperitoneal injection of streptozoto-
cin (STZ, Sigma) 50 mg/kg/day for 2 days. Draw blood from tail
vein was collected to detect blood glucose levels with a SURE-
STEP blood glucose meter (Lifescan) before STZ injection, every
week after STZ injection, and once additionally three days after
transplantation. One week after STZ injection the blood glucose
levels were over 400 mg/dl. Under anesthetized by intramuscular
injection of 10% chloride hydrate, the stage 4 insulin secreting
islet-like cell clusters (about 2610
6 cells) were transplanted into the
liver of the STZ-induced diabetic rats via laparotomy with a 22
#
needle slowly injected into liver parenchyma. Another group of
STZ-DM animals were treated with undifferentiated HUMSCs
(2610
6), and the other sham animals were treated with normal
saline. In some experiments, intraperitoneal glucose tolerance
(IPGT) test was performed with 1g/kg of glucose.
Immunocytochemistry
Cell clusters were fixed with 4% paraformaldehyde in 0.1 M
phosphate buffer for 20 min and then washed with 0.1 M
phosphate buffer. They were then treated with a blocking solution
for 30 min to prevent nonspecific antibody-antigen binding. The
cells clusters were then reacted with primary antibodies: mouse
anti-nestin, 1:100 (Abcam); mouse anti-human insulin 1:30 (Santa
Cruz Biotechnology); mouse anti-human nuclei, 1:30 (Chemicon);
rabbit anti-human glucagon 1:50 (Serotec), at 4uC for 18 h,
washed with 0.1 M phosphate-buffered saline (PBS), reacted with
secondary antibodies: rhodamine-conjugated goat anti-mouse
IgG, 1:50 for nestin and insulin; rhodamine-conjugated goat
anti-rabbit IgG, 1:50 for glucagons at room temperature for 1 h.
The cell clusters were then observed under a fluorescence
microscope. In some experiments, after reacted with primary
antibody (mouse anti-human insulin) and secondary antibody, the
cell clusters reacted with ABC complex (ABC KIT, Vector
laboratories) at room temperature for 1 h, washed with 0.1 M
PBS, and finally developed with 3,39-diaminobenzidine (DAB)
(1 mM DAB, 50 mM Tris buffer, pH 7.6, and 0.015% H2O2).
Immunohistochemistry
Livers were isolated and fixed in 10% neutral-buffered formalin.
After infiltrating with 30% sucrose solution in PBS, cut the tissue
using frozen sections and paraffin sections method. For antigen
retrieval, tissue sections on slides were immersed in borate buffer
solution (pH 8) jar and placed in pressure oven for about 20 min
until the cooker reached its maximum pressure. It was then heated
for another 5 min at maximum pressure. Thereafter, the pressure
was reduced and cooled in a bath of tap water. Then the sections
incubate in blocking solution at room temperature for 6 hours.
And they were incubated overnight at 4uC with the following
primary antibodies and dilutions: mouse anti-human nuclei
monoclonal antibody (Chemicon, 1:100); guinea pig anti-human
insulin antibody (Linco Research, 1:100). These two primary
Islet-Like Cluster from HUMSCs
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10 min in 0.1 M PBS, then incubated with secondary antibodies
(diluted according to the manufacturer’s instructions) for 1 h in
0.1 M PBS at room temperature. Secondary antibodies: FITC-
conjugated goat anti-mouse IgG, 1:50 for human insulin or
rhodamine-conjugated goat anti-rabbit IgG, 1:50 for human
nuclei in liver sections (Chemicon). Cell nuclei were visualized by
incubating 5 min with 49-6 9diamindino-2-phenylindole (DAPI)
(Sigma, 1:2000) in 0.1 M PBS. The immunohistochemistry
identification of human cells was performed by using a primary
mouse anti-human nuclei monoclonal antibody (Chemicon),
specific for all human cell types.
Electron Microscopic Study for Transplanted Liver
The rats with stage 4 cell clusters transplantation were sacrificed.
The livers were isolated and fixed with 4% paraformaldehyde and
2.5% glutaraldehyde, and then the samples were embedded in
epoxy resin (Spurr; EMS). Ultra-thin sections were cut in an
ultramicrotome, stained with 2% uranyl acetate for 15 min and
3% lead citrate for 3 min. Then the sections were observed under
a transmission electron microscope.
Statistical Analysis
The data are given as means6SEM. The significance of difference
was evaluated by the paired Students’ t-test. When more than one
group was compared with one control, significance was evaluated
according to one-way analysis of variance (ANOVA). Statistical
difference was indicated by P,0.05.
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